Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes

Area of Science:

• Neurology
• Vascular Biology
• Neuropsychiatry

Background:

• Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder.
• It involves the narrowing and occlusion of intracranial arteries, leading to collateral vessel formation.
• MMD is increasingly recognized for its association with diverse neuropsychiatric outcomes.

Purpose of the Study:

• To provide a comprehensive overview of Moyamoya disease.
• To explore the epidemiology, pathophysiology, clinical features, and diagnostic approaches to MMD.
• To review current research on the neuropsychiatric sequelae of MMD.

Main Methods:

• Literature review and synthesis of existing research on Moyamoya disease.
• Analysis of studies investigating the link between MMD and neuropsychiatric conditions.
• Examination of data on cognitive function, psychiatric disorders, and quality of life in MMD patients.

Main Results:

• MMD presents with progressive cerebrovascular stenosis and compensatory collateral formation.
• Significant associations exist between MMD and neuropsychiatric issues, including cognitive deficits and mood disorders.
• Patient quality of life is frequently impacted by these neurological and psychiatric complications.

Conclusions:

• MMD poses complex challenges, extending beyond cerebrovascular symptoms to affect mental health and cognitive function.
• Further research is needed to understand and manage the neuropsychiatric sequelae of MMD.
• Integrated approaches are crucial for addressing the multifaceted impact of MMD on patients' well-being.